Lifevantage (LFVN) Return on Assets ROA from the first quarter of 2026 to first quarter of 2026 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Lifevantage Corp  (NASDAQ: LFVN)


Lifevantage's ROA from the first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Lifevantage's ROA in the first quarter of 2026?
Lifevantage Corp achieved a return on average assets (ROA) of 4.42 % in its first quarter of 2026, which is below Lifevantage's average return on assets, which stands at 12.72%.

ROA decreased relative to the period ending Jun 30 2026, due to the decline in net income.

However, within the Healthcare sector 117 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the fourth quarter of 2026 from 618 to 723.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
I. Quarter		 (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter
Y / Y Total Assets Change -3.86 % -11.34 % -19.56 % -10.74 % 24.2 %
Y / Y Net Income Change - -34.71 % -60.75 % -89.18 % 18.02 %
Net Income (TTM) in million 3 5 6 8 10
Return On Assets (TTM) 4.42 % 8.16 % 8.96 % 11.56 % 14.51 %
LFVN's Total Ranking # 723 # 618 # 353 # 358 # 380
Total Assets (TTM) in million 59 64 62 61 62
Seq. Total Assets Change -7.19 % 2.68 % 1.57 % -0.67 % -14.42 %
Seq. Net Income Change - -6.09 % 393.48 % -87.19 % 10.01 %

LFVN's 5 Years Annual ROA >> Back to LFVN Management Effectiveness >> Compare LFVN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 44
Sector # 118
Overall # 780

Return On Assets Statistics
High Average Low
41.68 %
12.72 %
-1.22 %
(Jun 30 2012)   (Mar 31 2023)





Financial Statements
Lifevantage's Assets $ 59 million LFVN's Balance sheet
Lifevantage's Income $ 0 million Quarterly LFVN's Income Statement
LFVN's Income by Division See LFVN's Income by Division



Annual Return On Assets (Jun 30 2026)
FY 2026		 (Jun 30 2025)
FY 2025		 (Jun 30 2024)
FY 2024		 (Jun 30 2023)
FY 2023		 (Jun 30 2022)
FY 2022
Y / Y Total Assets Change 7.5 % 21.66 % -14.15 % -5.36 % -7.48 %
Total Assets in million 64 59 49 57 60
Y / Y Net Income Change -48.27 % 233.84 % 15.63 % -18.59 % -75.8 %
Net Income in million 5 10 3 3 3
Annual Return On Assets 7.95 % 16.52 % 6.02 % 4.47 % 5.2 %

LFVN's 5 Years Annual ROA >> Back to LFVN Management Effectiveness >> Compare LFVN ROA to its Competitors



Comment on LFVN's ROA in the fiscal year ending 2026
In the fiscal year 2026 Lifevantage's ROA decreased compared to previous year to 7.95 %, due to deterioration of net income -48.27 % to $5.07 million, from $9.81 million a year ago, as LFVN's assets were $63.80 million.


More Return On Assets Ratios
LFVN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
LFVN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for LFVN's Competitors
Subscribers only: Roa for Lifevantage's Suppliers
Subscribers only: Return On Assets for LFVN's Customers

You may also want to know
LFVN's Roi LFVN's Inventory Turnover Ratio LFVN's Growth Rates LFVN's Dividend Comparisons
LFVN's Profitability Ratios LFVN's Asset Turnover Ratio LFVN's Dividend Growth
LFVN's Roe LFVN's Valuation Ratios LFVN's Financial Strength Ratios LFVN's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %
Lantheus Holdings Inc   11.43 %
Msa Safety Inc  11.01 %
Encompass Health Corporation  10.99 %
Inspire Medical Systems inc   10.89 %
Transmedics Group Inc   10.67 %
Bristol myers Squibb Company  10.47 %
Lemaitre Vascular Inc   10.28 %
Beone Medicines Ltd   10.23 %
Amgen Inc   10.02 %
Bio rad Laboratories Inc   9.88 %
3m Company  9.60 %
Bioventus Inc   9.47 %
Medinotec Inc   8.67 %
Tactile Systems Technology Inc   8.53 %
Penumbra Inc  8.13 %
Johnson and Johnson  8.06 %
Pacific Health Care Organization Inc  7.83 %
Boston Scientific Corporation  7.82 %
Ani Pharmaceuticals Inc  7.77 %
Stryker Corp  7.66 %
Abbvie Inc   7.48 %
Ensign Group Inc  7.00 %
Pediatrix Medical Group Inc   6.99 %
Quest Diagnostics Inc  6.96 %
Davita Inc   6.65 %
Brightspring Health Services Inc   6.60 %
Ge Healthcare Technologies Inc   5.85 %

Date modified: 2026-11-11T02:40:39+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.